Clinical trial
Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study
NCT01018186
Study timeline
Study start (unknown)2009-10-19Date precision: day
Registry last updated2018-02-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
Fluticasone propionateDRUG · verified · RxNorm: fluticasone propionate
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
BerlinGermany5KyivUkraine5BangkokThailand2DallasTexas, United States1San AntonioTexas, United States1CincinnatiOhio, United States1Oklahoma CityOklahoma, United States1AustinTexas, United States1BethesdaMaryland, United States1RaleighNorth Carolina, United States1El PasoTexas, United States1Huntington BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01018186 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.